These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8112728)

  • 1. Epstein-Barr virus-related lymphomagenesis in a child with Wiskott-Aldrich syndrome.
    Gulley ML; Chen CL; Raab-Traub N
    Hematol Oncol; 1993; 11(3):139-45. PubMed ID: 8112728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.
    Cordier M; Calender A; Billaud M; Zimber U; Rousselet G; Pavlish O; Banchereau J; Tursz T; Bornkamm G; Lenoir GM
    J Virol; 1990 Mar; 64(3):1002-13. PubMed ID: 2154588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus infection and its gene expression in gastric lymphoma of mucosa-associated lymphoid tissue.
    Xu WS; Chan AC; Lee JM; Liang RH; Ho FC; Srivastava G
    J Med Virol; 1998 Dec; 56(4):342-50. PubMed ID: 9829640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
    Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G
    Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis.
    Peng M; Lundgren E
    Oncogene; 1992 Sep; 7(9):1775-82. PubMed ID: 1354347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Epstein-Barr virus latent infection genes and oncogenes in lymphoma cell lines derived from pyothorax-associated lymphoma.
    Kanno H; Yasunaga Y; Ohsawa M; Taniwaki M; Iuchi K; Naka N; Torikai K; Shimoyama M; Aozasa K
    Int J Cancer; 1996 Jul; 67(1):86-94. PubMed ID: 8690530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization.
    Knutson JC
    J Virol; 1990 Jun; 64(6):2530-6. PubMed ID: 2159528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of cellular gene expression in B lymphoma cells following in vitro infection by Epstein-Barr virus (EBV).
    Calender A; Cordier M; Billaud M; Lenoir GM
    Int J Cancer; 1990 Oct; 46(4):658-63. PubMed ID: 1698730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient expression of the Epstein-Barr virus LMP1 gene in B-cell chronic lymphocytic leukemia cells, T cells, and hematopoietic cell lines: cell-type-independent-induction of CD23, CD21, and ICAM-1.
    Peng M; Lundgren E
    Leukemia; 1993 Jan; 7(1):104-12. PubMed ID: 8093369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of a short Epstein-Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein-Barr nuclear antigens EBNA2 and EBNA5.
    Trivedi P; Cuomo L; de Campos-Lima PO; Imreh MP; Kvarnung K; Klein G; Masucci MG
    J Gen Virol; 1993 Jul; 74 ( Pt 7)():1393-8. PubMed ID: 8393080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
    Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
    Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene.
    Zimber-Strobl U; Suentzenich KO; Laux G; Eick D; Cordier M; Calender A; Billaud M; Lenoir GM; Bornkamm GW
    J Virol; 1991 Jan; 65(1):415-23. PubMed ID: 1845900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
    Doyle MG; Crawford DH
    Intervirology; 1994; 37(5):236-44. PubMed ID: 7698878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
    Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
    Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types.
    Hummel M; Anagnostopoulos I; Korbjuhn P; Stein H
    J Pathol; 1995 Mar; 175(3):263-71. PubMed ID: 7745495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BHRF1, the Epstein-Barr virus (EBV) homologue of the BCL-2 protooncogene, is transcribed in EBV-associated B-cell lymphomas and in reactive lymphocytes.
    Oudejans JJ; van den Brule AJ; Jiwa NM; de Bruin PC; Ossenkoppele GJ; van der Valk P; Walboomers JM; Meijer CJ
    Blood; 1995 Sep; 86(5):1893-902. PubMed ID: 7655018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus (EBV) nuclear-antigen-2-induced up-regulation of CD21 and CD23 molecules is dependent on a permissive cellular context.
    Cordier-Bussat M; Billaud M; Calender A; Lenoir GM
    Int J Cancer; 1993 Jan; 53(1):153-60. PubMed ID: 8416201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Epstein-Barr virus-infected cells in benign lymphadenopathy of patients seropositive for human immunodeficiency virus.
    Brousset P; Schlaifer D; Roda D; Massip P; Marchou B; Delsol G
    Hum Pathol; 1996 Mar; 27(3):263-8. PubMed ID: 8600041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.
    Deacon EM; Pallesen G; Niedobitek G; Crocker J; Brooks L; Rickinson AB; Young LS
    J Exp Med; 1993 Feb; 177(2):339-49. PubMed ID: 8381153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.